Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

BIOMARIN PHARMACEUTICAL INC (BMRN) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $89.36 Metrics
OS: 186.5 M
Market cap: $16.7 B
Net cash: $542 M $2.91 per share
EV: $16.1 B

 
TTM Valuation
EBITDA $56.3 M 286.2 x EV/EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues2,096.01,846.31,860.51,704.01,491.21,313.61,116.9889.9
            Revenue growth13.5%-0.8%9.2%14.3%13.5%17.6%25.5%18.8%
Cost of goods sold483.7470.5524.3359.5315.3241.8209.6152.0
Gross profit1,612.41,375.81,336.21,344.61,175.91,071.9907.2737.9
            Gross margin76.9%74.5%71.8%78.9%78.9%81.6%81.2%82.9%
Selling, general and administrative854.0759.4737.7680.9604.4554.3476.6402.3
Research and development649.6628.8628.1715.0696.3610.8661.9634.8
EBIT41.6-82.3-96.3-125.5-174.1-141.0-204.8-282.3
            EBIT margin2.0%-4.5%-5.2%-7.4%-11.7%-10.7%-18.3%-31.7%
Pre-tax income149.6-75.4-49.0-94.8-142.7-35.9-831.1-154.7
Income taxes8.0-11.3-903.0-71.0-65.581.2-200.817.1
            Tax rate5.4%15.0%1843.0%74.8%45.9% 24.2% 
Net income141.6-64.1854.0-23.8-77.2-117.0-630.2-171.8
            Net margin6.8%-3.5%45.9%-1.4%-5.2%-8.9%-56.4%-19.3%
 
Diluted EPS$0.75($0.35)$4.46($0.13)($0.44)($0.67)($3.79)($1.07)
Shares outstanding (diluted)189.0182.9191.7179.0177.3174.4166.2160.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy